Fortrea Holdings FTRE
NASDAQ FTRE
$18.26 -0.36 (-1.93%)
As of: Sep 4, 2026 · 11:45 AM EDT

Fortrea Holdings (FTRE) EBT (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly EBT came in at -$1.2 million in Q2 2026, up 99.68% YoY from -$600972.7 in Q2 2025, and up 90.24% on a QoQ basis from -$12.3 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) EBT (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of EBT data on file, last reported at -$1.2 million in Q2 2026.

  • Quarterly EBT rose 99.68% year-over-year to -$1.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$77.8 million (up 92.44% YoY) and the FY2025 annual result came in at -$983.0 million, down 257.45% from the prior year.
  • EBT rose to -$1.2 million in Q2 2026, from -$12.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $83.6 million in Q2 2022 to a low of -$548.0 million in Q1 2025.
  • A 5-year average of -$67.8 million and a median of -$28.7 million in 2025 frame the typical range for EBT.
  • Annual changes were most pronounced in 2024 — EBT slumped 896.84% — and 2026, when it soared 99.68%.
  • Tracing FTRE's EBT over 5 years: stood at -$8.3 million in 2022, then sank by 559.04% to -$54.7 million in 2023, then slumped by 36.93% to -$74.9 million in 2024, then jumped by 52.47% to -$35.6 million in 2025, then soared by 96.63% to -$1.2 million in 2026.
  • The last three EBT figures came in at -$1.2 million (Q2 2026), -$12.3 million (Q1 2026), and -$35.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 542.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -767.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 312.46 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 177.81 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 81.49 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn -11.37 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn -1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.20 Mn
Mar 31, 2026 -12.30 Mn
Dec 31, 2025 -35.60 Mn
Sep 30, 2025 -28.70 Mn
Jun 30, 2025 -370.70 Mn
Mar 31, 2025 -548.00 Mn
Dec 31, 2024 -74.90 Mn
Sep 30, 2024 -35.80 Mn
Jun 30, 2024 -88.60 Mn
Mar 31, 2024 -75.70 Mn
Dec 31, 2023 -54.70 Mn
Sep 30, 2023 -21.90 Mn
Jun 30, 2023 36.60 Mn
Mar 31, 2023 9.50 Mn
Dec 31, 2022 -8.30 Mn
Sep 30, 2022 74.20 Mn
Jun 30, 2022 83.60 Mn